In the STEMI Door-to-Unload trial, use of Impella missed the mark in patients with anterior MI without cardiogenic shock.

Please provide your email address to receive an email when new articles are posted on . Long-term follow-up from DANAMI-3-PRIMULTI shows reduction in events after complete revascularization vs.

Using a microaxial flow pump prior to and during cardiac stenting procedures for patients with severe heart attacks who don't have cardiogenic shock does not significantly reduce heart damage.

It's best to have patients on aggressive lipid-lowering therapy before discharge after an acute ST-segment elevation myocardial infarction (STEMI), so why not start it right away — even in the cath ...

For patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease, 10-year data from the DANAMI-3-PRIMULTI trial brought greater assurance that complete revascularization ...

Hudson Regional Hospital announced Jan. 9 that its Cardiac Catheterization Lab earned New State Department of Health approval for a diagnostic tool used to identify and treat patients with chest pain.

NEW ORLEANS — A glycoprotein IIb/IIIa inhibitor (GPI) that can be administered subcutaneously before a person having an ST-elevated myocardial infarction (STEMI) arrives at the hospital improved key ...

Operators safely shaved a few minutes off heart attack reperfusion times by taking patients straight to culprit lesion percutaneous coronary intervention (PCI) when they arrived at the catheterization ...

Patients who have a ST-segment-elevation myocardial infarction while hospitalized for other conditions experience delays in reperfusion when compared with those who have a STEMI while outside the ...

February is Heart Health Awareness Month, and it is an opportune time to shed light on a critical issue that can affect rural communities like Humboldt County — the urgent need for STEMI (ST-Elevation ...